0034-7418

0034-7418

S0034-74182021000100061

10.15446/rcciquifa.v50n1.89717

Brazil

Brazil

00 04 2021

00 04 2021

50 1 61 85

1

2014 9

113-24

2

2016 892

327-49

3

2009 47

640-7

4

2015 13

1433-40

5

2018 14

260-5

6

2018 28

374-8

7

2016 106

79-86

8

2016 9

1-6

9

2014 4

159-65

10

2014 4

1-6

11

ICH Harmonised Tripartite Guideline 2019

12

2014 68

221-38

13

2015 115

487-501

14

2013 49

89-99

15

2014 15

198-212

16

2013 10

2962-74

17

2020 13

4134-46

18

2020

19

2014 11

4179-88

20

2015 34

810-5

21

2019 9

300-6

22

2014 5

48-54

23

2017 10

93-107

24

2017 30

68-74

25

2019 8

103-8

26

2016 9

1428-34

27

2017 4

46-50

28

ICH Harmonised Tripartite Guideline

29

2001 24

723-53

30

2020

31

2015 58

4066-72

32

FDA Center for Drug Evaluation and Research 2019

33

2003 987

57-66

34

2007 59

29-37

35

1991 2

99-113

36

1998 63

1944-53

37

1989 12

2071-8

38

2019 16

6-15

39

2012 27

275-80

40

2017 53

1-7

41

2017 22

1-16

42

2019 380

114-692

43

2011 2

148-56